Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's Sarcoma
Clinical trial NCT03469804 · UNKNOWN
Trial details
- NCT number
- NCT03469804
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-01
- Primary completion
- 2020-03-20
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.